Intuitive Surgical Inc (ISRG) — closed signal from April 22, 2026
Partial Published before the outcome was known, scored automatically when the window closed on July 21, 2026 — -27.7% at the close.
Predicted vs. what happened
What happened
Reached 9% of the predicted growth at its peak, without hitting the target.
The thesis — published April 22, 2026
Intuitive showed a strong quarter with higher procedure growth and a better full-year outlook, reinforcing both growth and steady revenue from instruments and services. The price action after earnings looks orderly, not overstretched, so the stock appears positioned to follow through while short-term enthusiasm settles.
Primary drivers
- Company raised procedure forecasts after a strong quarter
- Repeating instrument and service sales provide steady revenue
- Wide adoption of the platform across current and new systems
- Post-earnings price action looks orderly, not extreme
How it played out
ISRG: the thesis didn't play out
Lyra published ISRG at $484.12 and expected 16% growth. The thesis pointed to higher procedure forecasts after a strong quarter, recurring instrument and service sales, wider platform adoption, and orderly price action after earnings. The published target was $561.57.
The stock peaked at $491.15 on April 22, a gain of 1.5%. It never reached the target during the window. By July 21, it had fallen to $350.06, well below both the publication price and target. The thesis did not play out.
What happened during the window
On May 21, Intuitive announced enhancements across da Vinci 5 and its supporting systems. On July 16, the company reported second-quarter revenue of $2.89 billion, up 19% from the prior-year quarter.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.